Your browser doesn't support javascript.
loading
Prevalence of lipodystrophy and risk factors for dyslipidemia in HIV-infected children in Brazil
Papi, Luanda; Menezes, Ana Carolina G.B.; Rocha, Hélio; Abreu, Thalita F.; Oliveira, Ricardo Hugo de; Frota, Ana Cristina C.; Evangelista, Lucia de A.; Hofer, Cristina B..
  • Papi, Luanda; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Menezes, Ana Carolina G.B.; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Rocha, Hélio; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Abreu, Thalita F.; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Oliveira, Ricardo Hugo de; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Frota, Ana Cristina C.; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Evangelista, Lucia de A.; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
  • Hofer, Cristina B.; Universidade Federal do Rio de Janeiro. Rio de Janeiro. BR
Braz. j. infect. dis ; 18(4): 394-399, Jul-Aug/2014. tab, graf
Article in English | LILACS | ID: lil-719294
ABSTRACT
The aim of present study was to describe the frequency of lipodystrophy syndrome associated with HIV (LSHIV) and factors associated with dyslipidemia in Brazilian HIV infected children. HIV infected children on antiretroviral treatment were evaluated (nutritional assessment, physical examination, and laboratory tests) in this cross-sectional study. Univariate analysis was performed using Mann-Whitney test or Fisher's exact test followed by logistic regression analysis. Presence of dyslipidemia (fasting cholesterol >200 mg/dl or triglycerides >130 mg/dl) was the dependent variable. 90 children were enrolled. The mean age was 10.6 years (3-16 years), and 52 (58%) were female. LSHIV was detected in 46 children (51%). Factors independently associated with dyslipidemia were low intake of vegetables/fruits (OR = 3.47, 95%CI = 1.04-11.55), current use of lopinavir/ritonavir (OR = 2.91, 95%CI = 1.11-7.67). In conclusion, LSHIV was frequently observed; inadequate dietary intake of sugars and fats, as well as current use of lopinavir/ritonavir was associated with dyslipidemia.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Anti-HIV Agents / HIV-Associated Lipodystrophy Syndrome / Dyslipidemias Type of study: Diagnostic study / Etiology study / Observational study / Prevalence study / Risk factors Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Braz. j. infect. dis Journal subject: Communicable Diseases Year: 2014 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal do Rio de Janeiro/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Anti-HIV Agents / HIV-Associated Lipodystrophy Syndrome / Dyslipidemias Type of study: Diagnostic study / Etiology study / Observational study / Prevalence study / Risk factors Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Braz. j. infect. dis Journal subject: Communicable Diseases Year: 2014 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal do Rio de Janeiro/BR